Free Trial

Ardent Health Partners, LLC (NYSE:ARDT) Receives Average Rating of "Buy" from Brokerages

Ardent Health Partners logo with Medical background

Shares of Ardent Health Partners, LLC (NYSE:ARDT - Get Free Report) have been given a consensus recommendation of "Buy" by the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, nine have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $20.67.

A number of research analysts have commented on ARDT shares. Royal Bank of Canada reaffirmed an "outperform" rating and set a $21.00 target price on shares of Ardent Health Partners in a report on Thursday, May 15th. Stephens restated an "overweight" rating and set a $21.00 price objective on shares of Ardent Health Partners in a research note on Tuesday, May 20th. Mizuho reduced their price target on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Guggenheim lifted their price target on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a report on Friday, May 9th.

View Our Latest Stock Report on Ardent Health Partners

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Rhumbline Advisers boosted its stake in Ardent Health Partners by 46.8% during the first quarter. Rhumbline Advisers now owns 24,827 shares of the company's stock valued at $341,000 after buying an additional 7,914 shares in the last quarter. Strs Ohio acquired a new position in shares of Ardent Health Partners in the 1st quarter worth approximately $494,000. Acadian Asset Management LLC grew its stake in shares of Ardent Health Partners by 574.9% in the 1st quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock worth $550,000 after purchasing an additional 34,276 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of Ardent Health Partners by 235.1% in the 1st quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock worth $790,000 after purchasing an additional 40,318 shares in the last quarter. Finally, SageView Advisory Group LLC acquired a new stake in Ardent Health Partners during the first quarter valued at approximately $2,327,000.

Ardent Health Partners Stock Down 0.8%

Ardent Health Partners stock traded down $0.10 during midday trading on Friday, hitting $13.32. 177,676 shares of the company were exchanged, compared to its average volume of 385,584. The company has a market cap of $1.91 billion and a PE ratio of 8.17. Ardent Health Partners has a fifty-two week low of $11.31 and a fifty-two week high of $20.72. The company's fifty day moving average price is $13.52 and its 200-day moving average price is $14.55. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, research analysts predict that Ardent Health Partners will post 1.23 EPS for the current fiscal year.

Ardent Health Partners Company Profile

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Should You Invest $1,000 in Ardent Health Right Now?

Before you consider Ardent Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.

While Ardent Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines